OPEN CLINICAL TRIALS
OPEN CLINICAL TRIALS
Embedded Files
What is a CLINICAL TRIAL? (NIH) Also, what "Phases" means.
*NEW* Myasthenia Gravis Rare Disease Network
Another reference (Myasthenia Gravis News)
And Another! (Bionews) Scroll down a bit
IGM-2644 is a potential first-in-class IgM T cell engager targeting CD38 in autoantibody-driven disease (Myasthenia Gravis News) A promising new type of MG drug therapy?
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis (NIH) This new clinical trial by COUR Pharmaceuticals will attempt to reprogram the immune system to eliminate Myasthenia Gravis symptoms. Here you can find just about all the information you need, including Study Overview, Participation Criteria, Study Locations (including contact information), and the Study Plan. Of the 13 trial sites, there currently are two locations in Southern California that are actively recruiting study participants.
For your reference here is a summary of the Phase 2 and Phase 3 MG Drug Trials (as of 2024) (source):
For your reference here is a summary of the Phase 2 and Phase 3 MG Drug Trials (as of 2024) (source):
Page updated
Google Sites
Report abuse